Compounds That Target EPHA5

EPH receptor A5 · 31 compounds in BiohacksAI corpus

EPHA5 (EPH receptor A5) is a biological target with 31 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into EPHA5 modulation for therapeutic and biohacking applications.

View EPHA5 target page →UniProt: P54756 ↗

Most Studied Compounds for EPHA5

Sorafenib

300+

studies

Crizotinib

298+

studies

All 31 Compounds — Ranked by Evidence

Gefitinib

5.67

confidence

Erlotinib

5.55

confidence

Alvocidib

4.52

confidence

Foretinib

4.34

confidence

Vandetanib

4.30

confidence

Ponatinib

4.26

confidence

Nilotinib

4.17

confidence

Bosutinib

4.08

confidence

Doramapimod

4.06

confidence

Regorafenib

3.56

confidence

Canertinib

3.53

confidence

Pelitinib

3.50

confidence

Tae 684

3.43

confidence

Linifanib

3.33

confidence

Mln 8054

3.33

confidence

Saracatinib

3.33

confidence

Neflamapimod

3.30

confidence

Dasatinib Anhydrous

3.09

confidence

Lestaurtinib

3.04

confidence

Danusertib

2.94

confidence

R 406

2.83

confidence

Milciclib

2.77

confidence

Gsk 690693

2.64

confidence

Tivozanib

2.64

confidence

Ast 487

2.56

confidence

Golvatinib

2.20

confidence

Cep 32496

1.95

confidence

Bafetinib

1.95

confidence

Sapitinib

1.95

confidence

Sorafenib

300+

studies

1.39

confidence

Crizotinib

298+

studies

0.69

confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for EPHA5 (EPH receptor A5). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: EPHA5 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.